Cargando…
Identification of proteins and cellular pathways targeted by 2-nitroimidazole hypoxic cytotoxins
Tumour hypoxia negatively impacts therapy outcomes and continues to be a major unsolved clinical problem. Nitroimidazoles are hypoxia selective compounds that become entrapped in hypoxic cells by forming drug-protein adducts. They are widely used as hypoxia diagnostics and have also shown promise as...
Autores principales: | Rashed, Faisal Bin, Stoica, Alexandru Cezar, MacDonald, Dawn, El-Saidi, Hassan, Ricardo, Carolynne, Bhatt, Bhumi, Moore, Jack, Diaz-Dussan, Diana, Ramamonjisoa, Nirilanto, Mowery, Yvonne, Damaraju, Sambasivarao, Fahlman, Richard, Kumar, Piyush, Weinfeld, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933538/ https://www.ncbi.nlm.nih.gov/pubmed/33640700 http://dx.doi.org/10.1016/j.redox.2021.101905 |
Ejemplares similares
-
Cellular mechanism of action of 2-nitroimidazoles as hypoxia-selective therapeutic agents
por: Rashed, Faisal Bin, et al.
Publicado: (2022) -
Influence of 2-Nitroimidazoles in the Response of FaDu Cells to Ionizing Radiation and Hypoxia/Reoxygenation Stress
por: Rashed, Faisal Bin, et al.
Publicado: (2023) -
Characterization of the Tumor Microenvironment and Tumor–Stroma Interaction by Non-invasive Preclinical Imaging
por: Ramamonjisoa, Nirilanto, et al.
Publicado: (2017) -
Effect of lipophilicity of nitroimidazoles on radiosensitization of hypoxic bacterial cells in vitro.
por: Anderson, R. F., et al.
Publicado: (1979) -
A New, Potent 2‐Nitroimidazole Nucleoside Hypoxic Cell Radiosensitizer, RP170
por: Sasai, Keisuke, et al.
Publicado: (1989)